Page last updated: 2024-11-01

niclosamide and Glaucoma

niclosamide has been researched along with Glaucoma in 1 studies

Niclosamide: An antihelmintic that is active against most tapeworms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p48)
niclosamide : A secondary carboxamide resulting from the formal condensation of the carboxy group of 5-chlorosalicylic acid with the amino group of 2-chloro-4-nitroaniline. It is an oral anthelmintic drug approved for use against tapeworm infections.

Glaucoma: An ocular disease, occurring in many forms, having as its primary characteristics an unstable or a sustained increase in the intraocular pressure which the eye cannot withstand without damage to its structure or impairment of its function. The consequences of the increased pressure may be manifested in a variety of symptoms, depending upon type and severity, such as excavation of the optic disk, hardness of the eyeball, corneal anesthesia, reduced visual acuity, seeing of colored halos around lights, disturbed dark adaptation, visual field defects, and headaches. (Dictionary of Visual Science, 4th ed)

Research Excerpts

ExcerptRelevanceReference
" We explored the effects of niclosamide on TGF-β1-induced fibrosis in these cells and examined its underlying mechanism of action."8.31Niclosamide inhibits TGF-β1-induced fibrosis of human Tenon's fibroblasts by regulating the MAPK-ERK1/2 pathway. ( Guo, J; Li, W; Liu, X; Wang, J; Wu, X; Zhang, L, 2023)
" We explored the effects of niclosamide on TGF-β1-induced fibrosis in these cells and examined its underlying mechanism of action."4.31Niclosamide inhibits TGF-β1-induced fibrosis of human Tenon's fibroblasts by regulating the MAPK-ERK1/2 pathway. ( Guo, J; Li, W; Liu, X; Wang, J; Wu, X; Zhang, L, 2023)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Zhang, L1
Li, W1
Liu, X1
Guo, J1
Wu, X1
Wang, J1

Other Studies

1 other study available for niclosamide and Glaucoma

ArticleYear
Niclosamide inhibits TGF-β1-induced fibrosis of human Tenon's fibroblasts by regulating the MAPK-ERK1/2 pathway.
    Experimental eye research, 2023, Volume: 235

    Topics: Cell Proliferation; Cells, Cultured; Cicatrix; Fibroblasts; Fibrosis; Glaucoma; Humans; MAP Kinase S

2023